ProductNum | picture | CAS No. | Name and description | Formula | Quick order |
---|---|---|---|---|---|
CLP1144 |
|
1401708-83-5 |
Dihexa (Synonyms: PNB-0408; N-hexanoic-Try-Ile-(6)-amino hexanoic amide; Hexanoyl-Tyr-Ile-Ahx-NH2) 98+% |
C27H44N4O5 | |
CL3074 |
|
928037-13-2 |
Golvatinib | E-7050 98+% |
C33H37F2N7O4 | |
CL2888 |
|
905854-02-6 |
Tivantinib | ARQ-197 98+% |
C23H19N3O2 | |
CL2448A |
|
1415560-69-8 |
Crizotinib hydrochloride | PF-02341066 hydrochloride 98+% |
C21H23Cl3FN5O | |
CL2448 |
|
877399-52-5 |
Crizotinib (PF-02341066) 98+% |
C21H22Cl2FN5O | |
CLA1359 |
|
1365287-97-3 |
Emibetuzumab (Anti-HGFR / c-Met) 95+% |
— | |
CLA1280 |
|
1174900-84-5 |
Ficlatuzumab (Anti-HGF / SF) 95+% |
— | |
CLA1270 |
|
1133766-06-9 |
Onartuzumab (Anti-HGFR / c-Met) 95+% |
— | |
CLA1225 |
|
872514-65-3 |
Rilotumumab (Anti-HGF / SF) 95+% |
— | |
CL1800 |
|
943540-75-8 |
JNJ-38877605 | JNJ 38877605 98+% |
C19H13F2N7 | |
CL2357 |
|
1022150-57-7 |
SGX-523 98+% |
C18H13N7S | |